Fourteen countries, our own people
Our own CRAs and regulatory specialists now cover eight EU member states, alongside our six delivery countries.
Eastern Europe, the Baltics, the Caucasus and Central Asia
- Armenia
- Croatia
- Czechia
- Georgia
- Latvia
- Lithuania
- Moldova
- Poland
- Romania
- Slovakia
- Spain
- Ukraine
- United Kingdom
- Uzbekistan
Our own CRAs and our own regulatory specialists. Not subcontractors.
Eight EU member states, one application
All eight sit under the EU Clinical Trials Regulation: one CTIS submission, with our own regulatory specialists handling each country's national part in the local language, and our own CRAs monitoring at site.
Our six delivery countries
Georgia is our largest delivery base, with Ukraine, Armenia, Moldova, Uzbekistan and the United Kingdom.
| Country | Country engagements | Review timelines |
|---|---|---|
| Georgia | 54 country engagements | Regulatory review 20–21 working days; local ethics committee four weeks, submitted first. |
| Ukraine | 10 country engagements | Regulatory authority 55 working days; local ethics committee 20 working days, in parallel. |
| Armenia | 7 country engagements | Regulatory authority and central ethics committee together, 60 working days. |
| Moldova | 5 country engagements | Regulatory authority 15 or 35 working days; local ethics committees in parallel. |
| Uzbekistan | 3 country engagements | Regulatory authority and central ethics committee together, 60 days. |
| United Kingdom | 2 country engagements | Combined MHRA and ethics review. |
Observed review periods from our own submissions, not statutory best cases. Where a query round arises, add roughly a month.